A revolutionary wearable patch capable of detecting early signs of the most deadly form of skin cancer has been created. This wireless device enables patients to conduct self-screening at home, potentially detecting melanoma sooner and reducing the need for unnecessary biopsies, as per scientists.
Developed by American researchers, the battery-free patch aims to make screening more accessible and less intrusive. They emphasized that skin cancer, especially melanoma, poses a significant threat among various diseases.
Melanoma UK estimates that over 19,000 individuals in the UK will receive melanoma diagnoses by 2025. Early detection plays a vital role in successful treatment, yet current diagnostic methods, primarily reliant on visual inspection, can be subjective and may miss crucial early warning signs.
Dr. Mohammad Moghimi, leading the project, explained that the new patch measures the bioimpedance, or electrical properties, of skin lesions in a simple and non-invasive manner. Bioimpedance assesses how easily electrical signals travel through living tissue.
Cancerous regions often exhibit different electrical properties than healthy skin. By analyzing bioimpedance, the patch can pinpoint abnormal areas that may necessitate further medical attention.
The research team at Wake Forest University School of Medicine in North Carolina devised a flexible, chip-less, battery-free patch that adheres directly to the skin and communicates wirelessly with a small reader device. In a trial involving 10 volunteers, the patch accurately measured bioimpedance using safe electrical signals. Statistical analyses confirmed significant distinctions between healthy and abnormal skin.
Published in Biomedical Innovations, the study showcased the patch’s ability to differentiate between healthy skin and concerning spots. It successfully detected unique electrical signals from suspicious moles or lesions irrespective of skin color.
Dr. Moghimi stressed the importance of early detection in treating skin cancer effectively, especially when access to specialized dermatology care is limited. The wearable patch is designed to be affordable, user-friendly, and suitable for monitoring suspicious skin lesions outside medical facilities.
Distinguished by its battery-free and chip-less design, the patch is lightweight, disposable, and cost-effective. Unlike visual inspection, it provides objective numerical data about skin health, reducing the need for unnecessary biopsies and aiding doctors in making informed decisions.
Additionally, the patch offers supplementary information about lesions, complementing other diagnostic techniques such as imaging-based methods. It is effective across all skin tones and can detect changes in small or visually ambiguous lesions.
Dr. Moghimi, an Assistant Professor of biomedical engineering at Wake Forest, highlighted the goal of making early skin cancer detection accessible to everyone. The team plans to enhance the patch by integrating conductive hydrogel electrodes for improved performance and comfort.
Future steps involve conducting larger clinical studies to evaluate the patch’s real-world effectiveness and its ability to distinguish between benign and malignant lesions accurately.
